[EN] OXOQUINOLINE DERIVATIVES AS MTH1 INHIBITORS FOR THE THERAPY OF CANCER<br/>[FR] DÉRIVÉS D'OXOQUINOLÉINE EN TANT QU'INHIBITEURS DE MTH1 POUR LA THÉRAPIE DU CANCER
申请人:CEMM - FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH
公开号:WO2016135138A1
公开(公告)日:2016-09-01
The present invention relates to oxoquinoline derivatives of formula (I) for use as medicaments as well as pharmaceutical compositions comprising these compounds, particularly for use as inhibitors of MTH1 and for use in the treatment or prevention of cancer.